Cadus Buy Hold or Sell Recommendation

KDUS -- USA Stock  

USD 1.60  0.01  0.63%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Cadus Corporation is 'Strong Hold'. Macroaxis provides Cadus Corporation buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Cadus positions. The advice algorithm takes into account all of Cadus Corporation available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Cadus buy-and-hold prospective. Please see also Cadus Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus.

Time Horizon

Risk Tolerance

Symbol
Execute Advice

Cadus Current Recommendation

SellBuy
Not Rated
For the selected time horizon Cadus Corporation has a risk adjusted performance of 0.0, jensen alpha of 0.0, total risk alpha of 0.0, sortino ratio of 0.0 and treynor ratio of 0.0
We provide buy or sell advice to complement the prevailing expert consensus on Cadus. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available at the time. To make sure Cadus is not overpriced, please confirm all Cadus fundamentals including its EBITDA as well as the relationship between Cash Flow from Operations and Retained Earnings . Please also double-check Cadus Corporation Price to Earning to validate your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Cadus Thematic Classifications

Biotech IdeaBiotech
Biotechnology and pharmaceuticals production and services

Institutional Investors

Security TypeSharesValue
Fny Managed Accounts LlcCommon Shares75 K119 K
Messner Smith Theme Value Investment Management LtdCommon Shares2 K3 K
Fny Managed Accounts LlcCommon Shares11.2 K16 K
Messner Smith Theme Value Investment Management LtdCommon Shares2 K3 K
Messner Smith Theme Value Investment Management LtdCommon Shares21 K26 K
Messner Smith Theme Value Investment Management LtdCommon Shares2 K2 K
Messner Smith Theme Value Investment Management LtdCommon Shares2 K2 K

Cadus Greeks

α
Alpha over DOW
=0.00
β
Beta against DOW=0.00
σ
Overall volatility
=0.73
Ir
Information ratio =0.00

Cadus Volatility Alert

Cadus Corporation exhibits very low volatility with skewness of 0.0 and kurtosis of 0.0. However, we advise investors to further study Cadus Corporation technical indicators to make sure all market info is available and is reliable.
    
 Better Than Average     
    
 Worse Than Average Compare Cadus to competition

Cadus Fundamental Vs Peers

FundamentalsCadusPeer Average
Return On Equity(7.91) % (15.17) %
Return On Asset(3.89) % (15.64) %
Current Valuation40.02 M152.14 B
Shares Outstanding26.29 M1.43 B
Shares Owned by Insiders0.09 % 6.91 %
Shares Owned by Institutions69.41 % 18.37 %
Price to Earning36.54 times40.69 times
Price to Book1.12 times14.44 times
EBITDA(2.46 M)1.41 B
Net Income(3.1 M)517.71 M
Cash and Equivalents2.31 M3.89 B
Cash per Share0.09 times5.17 times
Current Ratio3.79 times3.30 times
Book Value Per Share1.43 times13.64 times
Cash Flow from Operations(2.81 M)1.25 B
Earnings Per Share0.12 times2.30 times
Number of Employees510.67 K
Beta0.630.34
Market Capitalization42.06 M29.78 B
Total Asset41.5 M126.86 B
Retained Earnings(39.16 M)38.24 B
Working Capital40.89 M3.58 B
Current Asset41.29 M36.8 B
Current Liabilities399 K33.34 B
   Purchase by Icahn Carl C of 500 shares of Cadus [view details]

Cadus Alerts

Trading Alerts and Improvement Suggestions
Cadus may become a speculative penny stock
The company reported previous year revenue of . Net Loss for the year was (3.1 M) with profit before overhead, payroll, taxes, and interest of 0.
CADUS CORP currently holds about 2.31 M in cash with (2.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09.
Roughly 69.0% of the company shares are owned by institutional investors

Did You Try This Idea?

Run Pharmaceutical Products Thematic Idea Now
Pharmaceutical Products
Pharmaceutical Products Idea
Fama and French focus on testing asset pricing under different economic assumptions. Pharmaceutical Products theme has 61 constituents.
View All  Next Launch Pharmaceutical Products
Please see also Cadus Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus. Please also try Portfolio Reporting module to create custom reports across your portfolios and generate quick suggestion pitch.